Document Detail


Roles of SM22α in cellular plasticity and vascular diseases.
MedLine Citation:
PMID:  23030444     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
SM22α is a shape change and transformation sensitive 22 kDa actin-binding protein of the calponin family. It is ubiquitous to vascular and visceral smooth muscle, and is an early marker of smooth muscle differentiation. It is also present in fibroblasts, and some epithelium. SM22α may be involved in calcium-independent smooth muscle contraction. Recent evidence suggests that disruption of SM22α induces vascular inflammation and is involved in osteochondrogenesis in arterial diseases. This is consistent with activation of NF-κB signaling, where NF-κB activity is upregulated in vascular injury. High expression of SM22α inhibits cell proliferation in VSMCs and in injured arteries. SM22α acts as a tumor suppressor. Loss of its expression is an early event in cell transformation and the development of some tumors, coinciding with cellular plasticity.
Authors:
L- H Dong; P Lv; M Han
Related Documents :
16992244 - An electrophysiological study of the effects of atropine and physostigmine on transmiss...
11562674 - Mechanism mediating nitric oxide-induced inhibition in human jejunal longitudinal smoot...
239214 - Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. v. enhanc...
7162224 - Comparison of the effects of chloroquine quinacrine and quinidine on autonomic neuroeff...
12745424 - A model of human muscle energy expenditure.
1674914 - Interaction of ethanol and l-glutamate in the guinea pig ileum myenteric plexus.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-01
Journal Detail:
Title:  Cardiovascular & hematological disorders drug targets     Volume:  -     ISSN:  2212-4063     ISO Abbreviation:  Cardiovasc Hematol Disord Drug Targets     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101269160     Medline TA:  Cardiovasc Hematol Disord Drug Targets     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Biochemistry and Molecular Biology, Ministry of Education, Hebei Medical University, No. 361, Zhongshan East Road, Shijiazhuang, 050017, China. hanmei@hebmu.edu.cn.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Accumulation of elements by edible mushroom species: Part I. Problem of trace element toxicity in mu...
Next Document:  Platelets in Thrombosis and Hemostasis: Old Topic with New Mechanisms.